Traditional drug development takes years and costs billions — and often fails to produce effective disease treatments. Hebrew University Professor Yaakov Nahmias, using technology developed at the University, founded Tissue Dynamics, which is poised to disrupt the pharmaceutical industry for the benefit of patients suffering from all kinds of diseases. Pitching Tissue Dynamics, Nahmias was the winner of the NEXUS:ISRAEL “Be the Investor” contest this past May, earning him a spot at OurCrowd’s Global Investor Summit in Israel in February 2020.
Mayer Brown and the American Friends of the Hebrew University invite you to hear Yaakov Nahmias speak about this revolutionary technology. Please join us at Mayer Brown’s offices on Tuesday August 13th at 6pm.
Tuesday, August 13, 2019
1221 Avenue of the Americas
New York, NY 10020
+1 212 506 2500